ML 315 hydrochloride

• CAT Number: I040091
• CAS Number: 2172559-91-8
• Molecular Formula: C18H14Cl3N3O2
• Molecular Weight: 410.68
• Purity: ≥95%
• Synonyms: 5-(1,3-benzodioxol-5-yl)-N-[(3,5-dichlorophenyl)methyl]pyrimidin-4-amine;hydrochloride
• InChI: InChI=1S/C18H13Cl2N3O2.ClH/c19-13-3-11(4-14(20)6-13)7-22-18-15(8-21-9-23-18)12-1-2-16-17(5-12)25-10-24-16;/h1-6,8-9H,7,10H2,(H,21,22,23);1H
• InChIKey: MNCDEAAKKQCKSX-UHFFFAOYSA-N
• SMILES: C1OC2=C(O1)C=C(C=C2)C3=CN=CN=C3NCC4=CC(=CC(=C4)Cl)Cl.Cl

ML 315 hydrochloride (Cat No.: I040091) is a small-molecule compound that acts as a selective inhibitor of specific enzymes or signaling pathways involved in various cellular processes, such as growth, survival, and apoptosis. It is often studied for its potential therapeutic applications in cancer and neurodegenerative diseases. By targeting key proteins or receptors, ML 315 hydrochloride aims to disrupt abnormal cellular functions, offering a promising approach for treatment. Preclinical studies suggest it could be effective in treating specific cancers, though further research is necessary to confirm its clinical efficacy.

Reference

[1]. Coombs TC, et al. Small-molecule pyrimidine inhibitors of the cdc2-like (Clk) and dual specificity tyrosine phosphorylation-regulated (Dyrk) kinases: development of chemical probe ML315. Bioorg Med Chem Lett. 2013 Jun 15;23(12):3654-61.
[Content Brief]